Delivery Order SPE2DB20D3303-SPE2DB25FA4DM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,209.99 on September 15, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet unit dose packages (30 count). The contract is non-competitive and utilizes firm fixed pricing, with an ultimate completion date of September 16, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999...
- The Defense Logistics Agency awarded a $3,157.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $4,513.88. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with an ultimate completion date of September 15, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count) with a ceiling value of $1,393.00. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet units in a quantity of 30, with a ceiling value of $1,386.82. The order represents a competitively awarded, non-set-aside delivery order under a firm fixed price arrangement, with an ultimate completion date of August 25, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $7,988.25. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count), valued at $15,288.87. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA4DMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablet, unit dose, 30-count packages, with a ceiling value of $1,006.45. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 25, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs and other government healthcare systems. The company's federal contract portfolio demonstrates consistent capability in delivering both brand-name and generic medications across multiple therapeutic domains through competitive, firm fixed price arrangements with the Defense Logistics Agency. The Telmisartan-HCTZ delivery addresses pharmaceutical supply requirements for the military healthcare system, leveraging AmerisourceBergen's existing prime vendor status and established distribution infrastructure to support federal medical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/24/25 |